<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34704316</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3083</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>36</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title>
          <ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Papillon-Lefevre syndrome treated by acitretin: case report and cytokine profile.</ArticleTitle>
        <Pagination>
          <StartPage>e235</StartPage>
          <EndPage>e238</EndPage>
          <MedlinePgn>e235-e238</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.17772</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Leuenberger</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-8186-5529</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fischer</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mylonas</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huber</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Domizio</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gilliet</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Conrad</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-2547-3440</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hohl</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0001-6337-7110</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, University Hospital of Lausanne, CHUV, Lausanne, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA>
        <NlmUniqueID>9216037</NlmUniqueID>
        <ISSNLinking>0926-9959</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007641">Keratolytic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>LCH760E9T7</RegistryNumber>
          <NameOfSubstance UI="D017255">Acitretin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017255" MajorTopicYN="Y">Acitretin</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007641" MajorTopicYN="N">Keratolytic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010214" MajorTopicYN="Y">Papillon-Lefevre Disease</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>7</Hour>
          <Minute>25</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34704316</ArticleId>
        <ArticleId IdType="doi">10.1111/jdv.17772</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Toomes C, James J, Wood AJ et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999; 23: 421-424.</Citation>
        </Reference>
        <Reference>
          <Citation>Castori M, Madonna S, Giannetti L et al. Novel CTSC Mutations in a patient with Papillon-Lefèvre syndrome with recurrent pyoderma and minimal oral and palmo-plantar involvement. Br J Dermatol 2009; 160: 881-898.</Citation>
        </Reference>
        <Reference>
          <Citation>Adamsk Z, Burchardt D, Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M, Wyganowska-Świątkowska M. Diagnosis of Papillon-Lefèvre syndrome: review of the literature and a case report. Adv Dermatol Allergol 2020; 37: 671-676.</Citation>
        </Reference>
        <Reference>
          <Citation>Sadik C, Noack B, Schacher B, Pfeilschifter J, Mühl H, Eickholz P. Cytokine production by leukocytes of Papillon-Lefèvre syndrome patients in whole blood. Clin Oral Invest 2012; 16: 591-597.</Citation>
        </Reference>
        <Reference>
          <Citation>Ullbro C, Brown A, Twetman S. Preventive periodontal regimen in Papillon-Lefevre syndrome. Pediatr Dent 2005; 27: 226-232.</Citation>
        </Reference>
        <Reference>
          <Citation>Tu J, Yin Z, Guo J, He F, Long FY, Yin ZQ. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by downregulating IκBζ. Int. Immunopharmacol. 2020; 79: 106045.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
